The University of Texas Health Science Center at San Antonio
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center at San Antonio sits in the top decile of US sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center at San Antonio: 378 sponsored US clinical trials, 77 recruiting.
The University of Texas Health Science Center at San Antonio sponsors 378 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 264 completed. 41 of these trials are in Phase 3-4 (later-stage) and 124 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center at San Antonio ranks in the top decile of sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
264 of 284 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
378 total, page 2 of 8
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
NCT05838287
Dupilumab Effects Against Aeroallergen Challenge
NCT05720325
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
NCT05380401
Wellness App for Sleep Disturbance in Hematological Cancer Patients
NCT05294991
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
NCT05696691
Neural Connectivity During Therapy for Adolescent PTSD
NCT05423444
Quantifying Hepatic Mitochondrial Fluxes in Humans
NCT05305287
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
NCT04863950
Comparing Antipsychotic Medications in LBD Over Time
NCT05590637
Sacituzumab Govitecan in Recurrent Glioblastoma
NCT04559230
Enhancing Resiliency and Optimizing Readiness in Military Personnel
NCT05094115
Sex-specific Determinants of Early-phase Recovery From Skeletal Muscle Disuse
NCT04151901
Chronic Pain Management In Primary Care Using Behavioral Health Consultants
NCT04680000
Rapamycin - Effects on Alzheimer's and Cognitive Health
NCT04629495
Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
NCT04600466
Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) Heart and Lung Study
NCT05006729
SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan
NCT05057806
Placement of Antibiotic Powder in Wounds During the Emergency Room
NCT03765567
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
NCT03894917
Dapagliflozin Plus Pioglitazone in T1DM
NCT03878459
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
NCT03655015
The Effects of Bariatric Surgeries on Glucose Metabolism
NCT02823665
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
NCT02969798
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
NCT00992901
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
NCT01803451
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
NCT03160274
Chromosome 18 Clinical Research Center
NCT00227253
Multilevel Lifestyle Intervention to Improve Physical Function in Older Adults With Type 2 Diabetes
NCT06173804
Evaluating Sensory-Adapted Dental Care in Children With Sensory Processing Disorders
NCT06411808
Improving Informed Decision Making for Cancer Clinical Trial Participation
NCT03820687
Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2
NCT04081220
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients
NCT02891538
Crisis Response Planning in Military Personnel With Mild Traumatic Brain Injury
NCT07327567
SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial
NCT07280897
Genetic Investigation of Cancer Predisposition
NCT04620278
Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult Participants
NCT07602335
Real World Evaluation of the Effectiveness and Implementation of a Digital Health Therapeutic for OUD
NCT07348796
SGLT2i, Pioglitazone, and Ketone Production in T1D
NCT07056699
TEAPOT Study Multisite
NCT07565753
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
NCT06609343
Sarcopenia in Chronic Kidney Disease (CKD) Patients
NCT07437053
Modulating Inflammation in Neuro-Trauma
NCT07510074
SwallowFIT Study in Parkinson's Disease
NCT07356414
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
NCT07470606
Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)
NCT06795659
Piloting JUN_Pregnancy Mobile Medical App
NCT06636110
Accelerated Image-Guided Robotically Delivered Transcranial Magnetic Stimulation for Combat PTSD
NCT06587659
Ridge Preservation With FDBA (Freeze Dried Bone Allograft) Using Dexamethasone vs. Saline
NCT06556095
Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old
NCT06435338
Gingival Augmentation and Root Coverage With Superficial and Deep Cut Acellular Dermal Matrices
NCT05956496
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 45 |
| Phase 3 | 8 |
| Phase 4 | 33 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center at San Antonio pipeline
77 recruiting of 378 indexed (20% open); 264 completed (70%).
Phase mix: 41 late (III/IV) vs 124 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center at San Antonio: open-pipeline peers nationwide
Peers matched on 378 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center at San Antonio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 378 trials (± recruiting share)
- Northwell Health · 370 trials · 22% recruiting
- University of California, Irvine · 368 trials · 20% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
Sponsors near 20% open enrollment (± trial volume)
- M.D. Anderson Cancer Center · 20% recruiting · 2,692 trials
- University of Georgia · 20% recruiting · 59 trials
- University of Houston · 20% recruiting · 64 trials
- Florida International University · 20% recruiting · 89 trials
Related
What to do with this The University of Texas Health Science Center at San Antonio page
378 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center at San Antonio or any single study.
- 77 of The University of Texas Health Science Center at San Antonio's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition The University of Texas Health Science Center at San Antonio studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The University of Texas Health Science Center at San Antonio pipeline card: 378 registered trials from official public datasets.Report a data error.